is there an age limit for glp 1 GLP-1 Weight-Loss Drug Demonstration Begins July 2026 GLP-1 weight loss drugs are

Medical nutrition education, training, and competencies to advance guideline-based diet counseling by physicians: a science advisory from the American Heart Association

The prevalence of the other GI AEs is lower

GLP-1 receptor agonists carry a boxed warning regarding thyroid C-cell tumors observed in animal studies, and while the relevance to humans remains uncertain, patients with personal or family history of medullary thyroid carcinoma should not use these medications

Instead, a healthcare provider must determine whether a person meets clinical requirements for coverage based on their body weight and health status

These recommendations may prevent people with T2D and/or obesity from withdrawing from GLP-1 RAs treatment, thus benefitting from their superior effect on glycaemic control and weight loss